A paper published in two medical journals last week offers guidelines for physicians treating coronavirus patients requiring advanced life-saving therapies.Continue reading
Author Archive: AZBio
UArizona Health Sciences Researchers Identify Potential Pathway to Make Opioids Safer, More Effective
Researchers from the UArizona College of Medicine – Tucson found that inhibiting heat shock protein 90 in the spinal cord enhanced effectiveness of opioid therapy and could decrease its side effects.Continue reading
TGen and HonorHealth Initiate COVID-19 Combination Therapy of Atovaquone and Azithromycin
Established combination seen as safer option for coronavirus therapy; will add data to TGen COVID Immunity Study and virus sequencing effortsContinue reading
USPTO Launches Patents 4 Partnerships
USPTO launches platform to facilitate connections between patent holders and potential licensees in key technologies. Initial release focuses on COVID-19–related technologiesContinue reading
Pfizer and BioNTech Dose First Participants in the U.S. as Part of Global COVID-19 mRNA Vaccine Development Program
- First participants dosed at NYU Grossman School of Medicine and University of Maryland School of Medicine
- Pfizer and BioNTech ramping up manufacturing capabilities to further increase production capacity in 2020/2021
UArizona Researchers Team Up to Address COVID-19 with the Help of TRIF and BIO5 Support
Research projects will address the pandemic from various angles, including public health, virology and drug discovery.
Continue reading
AdvaMed Announces VentConnect Online Platform to Scale the Production and Distribution of Ventilators
New portal developed with the Aerospace Industries Association and Google connects ventilator component suppliers with manufacturersContinue reading
Roche’s COVID-19 antibody test receives FDA Emergency Use Authorization and is available in markets accepting the CE mark
- The serology test has a specificity greater than 99.8% and sensitivity of 100% (14 Days post-PCR confirmation)
- The high specificity of the test is crucial to determine reliably if a person has been exposed to the virus and if the patient has developed antibodies
- Roche will provide high double-digit millions of tests already in May for countries accepting the CE mark and in the U.S. under Emergency Use Authorization, further ramping up capacities thereafter
- The test is available on Roche’s cobas e analysers which are widely available around the world
Beacon Biomedical’s BeScreened-CRC Test Receives CPT Reimbursement Code
Beacon Biomedical’s BeScreened-CRC Test new CPT Reimbursement Code 0163U is now active for Colon Cancer Screening.Continue reading
COVID-19 Update #4 shared by an Arizona Emergency Physician and Legislator
Amish Shah, MD is an emergency physician at Dignity Health and a member of the Arizona House of Representative elected by the people of LD24 – Central Phoenix and South Scottsdale. On Sunday, May 3, 2020, Dr. Shah shared the message below via Facebook. With his permission, we are sharing it with you. Continue reading